REMSleep Holdings, Inc. RMSL

Company Overview

REMSleep Holdings, Inc. (OTC: RMSL) is a medical technology and healthcare device company focused on respiratory care and sleep-related disorders. The company has concentrated its development efforts on non-invasive ventilation and positive airway pressure technologies intended for patients with obstructive sleep apnea, chronic obstructive pulmonary disease (COPD), and related respiratory conditions. Public disclosures indicate that the company’s primary commercial focus has been the development and planned commercialization of its proprietary ventilation platform known as the DeltaWave system.

The company operates within the broader medical device and respiratory therapy industries, targeting healthcare providers, sleep clinics, respiratory specialists, and home healthcare markets. REMSleep Holdings evolved from earlier corporate structures and shifted strategic emphasis toward respiratory technology development and intellectual property commercialization. Available public information suggests the company’s positioning has centered on attempting to differentiate its technology through pressure-delivery design and patient comfort objectives, although large-scale commercial adoption data remains limited in public filings.